Au W Y, Weisenburger D D, Intragumtornchai T, et al. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International peripheral T-cell Lymphoma project [J]. Blood, 2009, 113(17):3931-3937.
[2]
Swerdlow S H, Campo E, Pileri S A, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms [J]. Blood, 2016, 127(20):2375-2390.
[3]
Kim S H,Seon H J,Choi Y D,et al. Clinico-radiologic findings in primary cutaneous extranodal natural killer/t-cell lymphoma,nasal type mimicking cellulitis of the left arm [J]. Iran J Radiol,2015,12 ( 1): e12597.
Carroll G, Breidahl W, Robbins P .Musculoskeletal lymphoma: MRI of bone or soft tissue presentations[J]. J Med Imaging and Radiation Oncol,2013,57(6):663-673.
Lee W J, Lee M H, Won C H, et al. Comparative histopathologic analysis of cutaneous extranodal natural killer/T-cell lymphomas according to clinical morphology[J].J Cutan pathol,2015, 43(4):324-333.
[11]
Vazquez A, Khan M N, Blake D M, et al. Extranodal natural killer/T-cell lymphoma: population-based comparison of sinonasal and extranasal disease[J].Laryngoscope,2014,124(4):88-95.
[12]
Foss F,Advani R,Duvic M,et al. A Phase II trial of Belinostat ( PXD101) in patients with relapsed or refractory peripheral orcutaneous T-cell lymphoma[J].Br J Haematol,2015,168 (6): 811-819.
2021, Vol. 32 
